Status:
COMPLETED
A Study of Gaboxadol in Primary Insomnia
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Primary Insomnia
Eligibility:
All Genders
66+ years
Phase:
PHASE3
Brief Summary
To evaluate the efficacy safety and tolerability of gaboxadol in primary insomnia.
Detailed Description
To compare hypnotic efficacy of gaboxadol with placebo in elderly outpatients with primary insomnia
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with a diagnosis of primary insomnia
Exclusion
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2005
Estimated Enrollment :
505 Patients enrolled
Trial Details
Trial ID
NCT00209924
Start Date
April 1 2004
End Date
November 1 2005
Last Update
March 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Non-US study, principal location:
Gothenburg, Sweden